ATE88711T1 - Glycerol-derivate, ihre herstellung und ihre therapeutische verwendung. - Google Patents
Glycerol-derivate, ihre herstellung und ihre therapeutische verwendung.Info
- Publication number
- ATE88711T1 ATE88711T1 AT87301283T AT87301283T ATE88711T1 AT E88711 T1 ATE88711 T1 AT E88711T1 AT 87301283 T AT87301283 T AT 87301283T AT 87301283 T AT87301283 T AT 87301283T AT E88711 T1 ATE88711 T1 AT E88711T1
- Authority
- AT
- Austria
- Prior art keywords
- sup
- sub
- group
- glycerol derivatives
- production
- Prior art date
Links
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical class OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- 239000005864 Sulphur Substances 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 150000002314 glycerols Chemical class 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001841 imino group Chemical group [H]N=* 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 230000035939 shock Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/653—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2962486 | 1986-02-13 | ||
| EP87301283A EP0238202B1 (de) | 1986-02-13 | 1987-02-13 | Glycerol-Derivate, ihre Herstellung und ihre therapeutische Verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE88711T1 true ATE88711T1 (de) | 1993-05-15 |
Family
ID=12281241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87301283T ATE88711T1 (de) | 1986-02-13 | 1987-02-13 | Glycerol-derivate, ihre herstellung und ihre therapeutische verwendung. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5068340A (de) |
| EP (1) | EP0238202B1 (de) |
| JP (1) | JP2556849B2 (de) |
| KR (1) | KR950005742B1 (de) |
| AT (1) | ATE88711T1 (de) |
| CA (1) | CA1314889C (de) |
| DE (1) | DE3785599T2 (de) |
| ES (1) | ES2054663T3 (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0301751B1 (de) * | 1987-07-31 | 1993-03-10 | Takeda Chemical Industries, Ltd. | Pyridinium-Derivate, ihre Herstellung und Verwendung |
| US4920134A (en) * | 1987-08-07 | 1990-04-24 | Takeda Chemical Industries, Ltd. | 2-O-pyrimidinyl glycerol derivatives |
| EP0356765A3 (de) * | 1988-08-19 | 1991-08-07 | Takeda Chemical Industries, Ltd. | Carbonsäurederivate, deren Herstellung und Verwendung |
| EP0378763A1 (de) * | 1988-10-27 | 1990-07-25 | Takeda Chemical Industries, Ltd. | Lipide, ihre Herstellung und Verwendung |
| GB8904174D0 (en) * | 1989-02-23 | 1989-04-05 | British Bio Technology | Compounds |
| ES2010145A6 (es) * | 1989-03-02 | 1989-10-16 | Uriach & Cia Sa J | Procedimiento para la obtencion de derivados de la 2-picolilamina. |
| US5192766A (en) * | 1989-04-28 | 1993-03-09 | Sankyo Company, Limited | N-acryloylpiperazine derivatives, their preparation and their use as PAF antagonists |
| US5369106A (en) * | 1989-04-28 | 1994-11-29 | Sankyo Company, Limited | N-acryloylpiperazine derivatives, their preparation and their use of PAF antagonists |
| GB9009469D0 (en) * | 1990-04-27 | 1990-06-20 | British Bio Technology | Compounds |
| IE912874A1 (en) * | 1990-08-15 | 1992-02-26 | British Bio Technology | Compounds |
| US5274094A (en) * | 1990-08-15 | 1993-12-28 | British Bio-Technology Limited | Production of heterobicyclic containing benzene sulfonamides |
| GB9104746D0 (en) * | 1991-03-06 | 1991-04-17 | British Bio Technology | Compounds |
| GB9114337D0 (en) * | 1991-07-03 | 1991-08-21 | British Bio Technology | Compounds |
| GB9116056D0 (en) * | 1991-07-24 | 1991-09-11 | British Bio Technology | Compounds |
| GB9122308D0 (en) * | 1991-10-21 | 1991-12-04 | British Bio Technology | Compounds |
| ES2062943B1 (es) * | 1993-03-23 | 1995-11-16 | Uriach & Cia Sa J | Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas. |
| KR100789323B1 (ko) | 2005-07-20 | 2007-12-28 | 주식회사 엔지켐 | 글리세롤 유도체의 위치 선택적 제조방법 및 그 중간체 |
| TWI385169B (zh) | 2005-10-31 | 2013-02-11 | Eisai R&D Man Co Ltd | 經雜環取代之吡啶衍生物及含有彼之抗真菌劑 |
| TW200841879A (en) * | 2007-04-27 | 2008-11-01 | Eisai R&D Man Co Ltd | Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same |
| US8513287B2 (en) * | 2007-12-27 | 2013-08-20 | Eisai R&D Management Co., Ltd. | Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same |
| US8188119B2 (en) | 2008-10-24 | 2012-05-29 | Eisai R&D Management Co., Ltd | Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same |
| JP2012176900A (ja) * | 2009-06-24 | 2012-09-13 | Eisai R & D Management Co Ltd | （（ホスホノオキシ）メチル）ピリジニウム環を有するピリジン誘導体およびそれらを含有する抗真菌剤 |
| NZ746603A (en) | 2010-11-16 | 2020-05-29 | Texas Heart Inst | Agonists that enhance binding of integrin-expressing cells to integrin receptors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4408052A (en) * | 1980-02-27 | 1983-10-04 | Takeda Chemical Industries, Ltd. | Phospholipid carbamates |
| JPS60104066A (ja) * | 1983-11-10 | 1985-06-08 | Ono Pharmaceut Co Ltd | グリセリン誘導体 |
| US4650791A (en) * | 1984-01-11 | 1987-03-17 | Takedo Chemical Industries, Ltd. | Certain 3-alkoxy-2-cyclic-imido-propyl-phosphate-ethyl-cyclic ammonium hydroxide inner salts which inhibit activities of platelet activating factor |
| JPS60146894A (ja) * | 1984-01-11 | 1985-08-02 | Takeda Chem Ind Ltd | リン脂質 |
| DE3586746D1 (de) * | 1984-04-03 | 1992-11-19 | Takeda Chemical Industries Ltd | Lipidderivate, ihre produktion und verwendung. |
| JPS61267592A (ja) * | 1985-01-16 | 1986-11-27 | Sankyo Co Ltd | 燐酸エステル誘導体、その製法およびそれを含有する抗腫瘍剤 |
| US4891363A (en) * | 1985-07-26 | 1990-01-02 | Sankyo Company Limited | Cyclic ether derivatives and their use |
| GB8713745D0 (en) * | 1987-06-12 | 1987-07-15 | Scras | Aminoacylates of glycerol |
-
1987
- 1987-02-12 JP JP62028075A patent/JP2556849B2/ja not_active Expired - Lifetime
- 1987-02-13 AT AT87301283T patent/ATE88711T1/de not_active IP Right Cessation
- 1987-02-13 CA CA000529667A patent/CA1314889C/en not_active Expired - Fee Related
- 1987-02-13 DE DE87301283T patent/DE3785599T2/de not_active Expired - Fee Related
- 1987-02-13 KR KR1019870001218A patent/KR950005742B1/ko not_active IP Right Cessation
- 1987-02-13 EP EP87301283A patent/EP0238202B1/de not_active Expired - Lifetime
- 1987-02-13 ES ES87301283T patent/ES2054663T3/es not_active Expired - Lifetime
-
1989
- 1989-06-16 US US07/368,132 patent/US5068340A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0238202A2 (de) | 1987-09-23 |
| KR950005742B1 (ko) | 1995-05-30 |
| EP0238202B1 (de) | 1993-04-28 |
| US5068340A (en) | 1991-11-26 |
| ES2054663T3 (es) | 1994-08-16 |
| KR870007926A (ko) | 1987-09-22 |
| DE3785599D1 (de) | 1993-06-03 |
| CA1314889C (en) | 1993-03-23 |
| JP2556849B2 (ja) | 1996-11-27 |
| DE3785599T2 (de) | 1993-11-04 |
| EP0238202A3 (en) | 1988-12-07 |
| JPS62277368A (ja) | 1987-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3785599T2 (de) | Glycerol-derivate, ihre herstellung und ihre therapeutische verwendung. | |
| IE781878L (en) | Imidazole derivatives | |
| ATE97914T1 (de) | Perhydrothiazepinderivate, ihre herstellung und ihre therapeutische verwendung. | |
| ES8802153A1 (es) | Procedimiento para preparar derivados de isoxazol y furano. | |
| ATE2322T1 (de) | Substituierte imidazole, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| DK0452873T3 (da) | 1,8-naphthyridin-2-on-derivater | |
| ES8105298A1 (es) | Un procedimiento para la preparacion de imidazol-cianoguani-dinas. | |
| ES2059755T3 (es) | Derivados organicos de hidrazina para uso farmaceutico. | |
| ATE13178T1 (de) | 2-oxoazetidin-derivate, ihre herstellung und verwendung. | |
| FI851261L (fi) | Substituerade bensopyraner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel. | |
| DE69202120D1 (de) | Harnstoffderivate, ihre Herstellung und ihre Verwendung bei der Therapie. | |
| ES2005074A6 (es) | Procedimiento para la preparacion de difenilpiperidinas n-sustituidas | |
| ATE65084T1 (de) | Hydrierte 1-benzooxacycloalkylpyridincarbons|ureverbindungen. | |
| EP0279707A3 (de) | Aryloxymethylderivate von stickstoffhaltigen heterocyclischen Methanolen und ihre Ether mit cardiovaskularer Wirkung | |
| NO852514L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-alkyltio-2-piperazino-pyrimido (5,4-d) pyrimidin-derivater. | |
| ATE36854T1 (de) | Tetrahydrothienopyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel. | |
| DE3770321D1 (de) | 1,5-benzothiazepinderivate, deren herstellung und deren verwendung in der therapie. | |
| DE3060153D1 (en) | Derivatives of substituted 2-benzoyl glycinanilides, their preparation and their use in anxiolytic medicaments | |
| FI883745A0 (fi) | Nya kondenserade diazepinoner, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel. | |
| ATE38675T1 (de) | Phosphatesterderivate und ihre verwendung als anti-krebsmittel. | |
| DE59108859D1 (de) | 3,7-Diazabicyclo(3,3,1)-nonan-Verbindungen enthaltende Arzneimittel | |
| ES2000058A6 (es) | Un procedimiento para preparar deircados de ester de fosfato | |
| EP0034002A3 (de) | Carboxamidinderivate | |
| EP0292800A3 (de) | Aminosäurederivate | |
| EP0342325A3 (de) | Renin inhibierende Aminosäurederivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |